Literature DB >> 22710707

Long-term survival of older breast cancer patients: population-based estimates over three decades.

Bindu Kanapuru1, William B Ershler, Charles Hesdorffer, Ahmedin Jemal, Jerome W Yates.   

Abstract

Significant progress has been made in the treatment of breast cancer. However, treatment effect on survival in older patients, particularly the "oldest old" (85+ years), with breast cancer is not clear. Data from the Surveillance, Epidemiology, and End Results databases were used to determine relative survival of older patients with breast cancer for up to 9 years following diagnosis. We compared trends in survival and stage distribution in the years 1977-1986, 1987-1996, and 1997-2006 in patients from 65 to 74, 75 to 84, and 85+ years of age. Between 1977-1986 and 1997-2006, 1 year survival increased from 94.9 to 97.9 %, 93.6 to 96.7 %, and 88.5 to 93.5 % in the 65-74, 75-84, and 85+ age groups, respectively. Survival gains increased with each year in all three age groups with the largest improvement seen at 9 years of follow-up. Although the "oldest old" had the lowest survival rates, improvement in survival was greatest in this age group with greater than 20 % increase in survival at 9 years. There was an increased diagnosis of localized breast cancer and decrease in regional disease in all age groups over the three decades. In conclusion, relative survival for older patients has increased considerably in the interval between 1977 and 2006, with the largest improvement seen in those 85 years and older. These results likely indicate that the benefit from advances in therapy and supportive care also extends to older patients with breast cancer, including the 'oldest old', but the impact of early diagnosis on survival requires further clarification.

Entities:  

Mesh:

Year:  2012        PMID: 22710707     DOI: 10.1007/s10549-012-2115-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  7 in total

Review 1.  The impact of modern radiotherapy on long-term cardiac sequelae in breast cancer survivor: a focus on deep inspiration breath-hold (DIBH) technique.

Authors:  V Salvestrini; G C Iorio; P Borghetti; F De Felice; C Greco; V Nardone; A Fiorentino; F Gregucci; I Desideri
Journal:  J Cancer Res Clin Oncol       Date:  2021-12-01       Impact factor: 4.553

2.  Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA).

Authors:  David Miles; José Baselga; Dino Amadori; Patrapim Sunpaweravong; Vladimir Semiglazov; Adam Knott; Emma Clark; Graham Ross; Sandra M Swain
Journal:  Breast Cancer Res Treat       Date:  2013-10-16       Impact factor: 4.872

Review 3.  Intensity-modulated radiation therapy for early-stage breast cancer: is it ready for prime time?

Authors:  Tabitha Y Chan; Poh Wee Tan; Johann I Tang
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-03-20

4.  Voluntary Deep Inspiration Breath-hold Reduces the Heart Dose Without Compromising the Target Volume Coverage During Radiotherapy for Left-sided Breast Cancer.

Authors:  Noora Al-Hammadi; Palmira Caparrotti; Carole Naim; Jillian Hayes; Katherine Rebecca Benson; Ana Vasic; Hissa Al-Abdulla; Rabih Hammoud; Saju Divakar; Primoz Petric
Journal:  Radiol Oncol       Date:  2018-02-23       Impact factor: 2.991

Review 5.  Dosimetric evaluation and systematic review of radiation therapy techniques for early stage node-negative breast cancer treatment.

Authors:  Tabitha Y Chan; Johann I Tang; Poh Wee Tan; Neill Roberts
Journal:  Cancer Manag Res       Date:  2018-10-23       Impact factor: 3.989

6.  Net survival differences of breast cancer between stages at diagnosis and age groups in the east coast region of West Malaysia: a retrospective cohort study.

Authors:  Tengku Muhammad Hanis; Najib Majdi Yaacob; Suhaily Mohd Hairon; Sarimah Abdullah
Journal:  BMJ Open       Date:  2021-05-18       Impact factor: 2.692

7.  RecQL4 helicase amplification is involved in human breast tumorigenesis.

Authors:  Hongbo Fang; Linghu Nie; Zhenfen Chi; Jing Liu; Dan Guo; Xuemei Lu; Tom K Hei; Adayabalam S Balajee; Yongliang Zhao
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.